What is the global market size of Plasma Fractionation Market?

Plasma Fractionation Market size was valued at USD 28.50 billion in 2021 and is poised to grow from USD 30.87 billion in 2022 to USD 58.24 billion by 2030, at a CAGR of 8.3% during the forecast period (2023-2030).

Who are the key vendors in the Global Plasma Fractionation Market?

To improve their market position, key companies in this market are using a variety of strategies, such as alliances through mergers and acquisitions, geographic expansion, and strategic collaborations. For instance, Terumo Blood and Cell Technologies debuted its most recent production plant in May 2022 in Douglas County, Colorado. The modern production plant, which cost USD $250 million, is in line with the company's goals of improving society via healthcare and serving more people. The 170,000 square foot facility will provide one-time use collection sets for the recently FDA authorized Rika Plasma Donation System, which will give clients (Rika) access to source plasma collections. 'CSL Behring', 'Grifols', 'Octapharma', 'Baxalta/Shire', 'Kedrion', 'China Biologic Products Holdings', 'Sanquin', 'Bio Products Laboratory', 'Japan Blood Products Organization', 'LFB Group', 'Shanghai RAAS Blood Products', 'Green Cross Corporation', 'Baxter International Inc.', 'Takeda Pharmaceutical Company Limited', 'Beijing Tiantan Biological Products', 'Biotest AG', 'China National Pharmaceutical Group Co. (Sinopharm)', 'GC Pharma', 'ADMA Biologics', 'Emergent BioSolutions'

What is the key driver of Global Plasma Fractionation Market?

The aging population is another major driver of the plasma fractionation market. As people age, they are more likely to develop chronic diseases and require medical treatments, including plasma-derived products.

What is the key market trend for Global Plasma Fractionation Market?

Growing Demand for Immunoglobulins: The demand for immunoglobulins is increasing due to their use in the treatment of immune deficiencies and autoimmune diseases. As a result, there has been a significant increase in the production and use of immunoglobulins, which is driving market growth.

Which region accounted for the largest share in Global Plasma Fractionation Market?

North America has a 53.93% share of the regional market, dominating it. This is a result of both an increase in the prevalence of respiratory illnesses and growing knowledge of the many benefits of plasma among North American citizens. The expansion of the regional market is further aided by the existence of key players, an increase in the quantity of plasma collection facilities, a rise in the consumption of plasma collections and distribution of immunoglobulin, and the availability of plasma.

Plasma Fractionation Companies

Plasma Fractionation Market Competitive Landscape

Top Player’s Company Profiles in Plasma Fractionation Industry

CSL Behring (Australia)
Grifols (Spain)
Octapharma (Switzerland)
Kedrion (Italy)
China Biologic Products Holdings (China)
Sanquin (Netherlands)
Bio Products Laboratory (UK)
Japan Blood Products Organization (Japan)
LFB Group (France)
Shanghai RAAS Blood Products (China)
Green Cross Corporation (South Korea)
Baxter International Inc. (US)
Takeda Pharmaceutical Company Limited (Japan)
Beijing Tiantan Biological Products (China)
Biotest AG (Germany)
China National Pharmaceutical Group Co. (Sinopharm) (China)
GC Pharma (South Korea)
ADMA Biologics (US)
Emergent BioSolutions (US)
Renishaw plc (UK)
HP Inc. (USA)

Plasma Fractionation Industry

FAQs

Global Plasma Fractionation Market size was valued at around USD 30.87 billion in 2022 and is expected to rise from USD 33.43 billion in 2023 to reach a value of USD 63.27 billion by 2031, at a CAGR of 8.3% over the forecast period (2024–2031).

The plasma fractionation market remains controlled by both historical firms and new entrants which are boosting growth and creativity. Examples of major scion companies are Grifols, CSL Behring, Takeda Pharmaceutical Company, and Octapharma, whose focus is on improving product development and industrial expansion within international borders. These firms invest significantly in research and development to improve processing technologies and product efficacy, positioning themselves strategically to meet the increasing demand for plasma-derived therapies worldwide. 'CSL Behring (Australia) ', 'Grifols (Spain) ', 'Octapharma (Switzerland) ', 'Kedrion (Italy) ', 'China Biologic Products Holdings (China) ', 'Sanquin (Netherlands) ', 'Bio Products Laboratory (UK) ', 'Japan Blood Products Organization (Japan) ', 'LFB Group (France) ', 'Shanghai RAAS Blood Products (China) ', 'Green Cross Corporation (South Korea) ', 'Baxter International Inc. (US) ', 'Takeda Pharmaceutical Company Limited (Japan) ', 'Beijing Tiantan Biological Products (China) ', 'Biotest AG (Germany) ', 'China National Pharmaceutical Group Co. (Sinopharm) (China) ', 'GC Pharma (South Korea) ', 'ADMA Biologics (US) ', 'Emergent BioSolutions (US) ', 'Renishaw plc (UK) ', 'HP Inc. (USA)'

The rising number of cases relating to diseases related to immunodeficiency disorders and autoimmune conditions stands as an important factor fueling the growth of the global plasma fractionation market. Healthcare professionals use Immunoglobulins for these purposes which causes the demand for these products to spike. This trend stimulates creativity and growth in the development and emergence of plasma-based therapeutic products purification processes and manufacturing.

There is rising demand for specialized plasma products like immunoglobulins and clotting factor concentrates in the global plasma fractionation market. This is due to the increasing incidence of chronic and autoimmune disorders which requires detailed and effective treatment methods for patients.

Owing to the presence of an advanced healthcare system, extensive research and development activities, and high expenditure on biopharmaceuticals, North America holds the largest global plasma fractionation market share. Health care services and the concept of personalized medicine within these advanced health care systems also contribute to the market for plasma-based medical products, especially immunoglobins and albumin. Moreover, the existence of essential contributors to the market coupled with strong regulatory policies helps in ensuring the safety and effectiveness of the products. The calling burden of chronic diseases is on the rise, and plasma therapies are becoming popular among both practitioners and patients which also serves to enhance the growth of the market in North America, further solidifying its position in the global plasma fractionation market outlook.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Plasma Fractionation Market Size, Share, Growth Analysis, By Product (Albumin, Immunoglobulins (Intravenous, Subcutaneous, Others)), By Application (Neurology, Hematology, Oncology, Immunology), By End Use (Hospitals & Clinics, Clinical Research, and Others), By Region - Industry Forecast 2025-2032

Plasma Fractionation Market Competitive Landscape

Plasma Fractionation Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Plasma Fractionation Market Size, Share, Growth Analysis, By Product (Albumin, Immunoglobulins (Intravenous, Subcutaneous, Others)), By Application (Neurology, Hematology, Oncology, Immunology), By End Use (Hospitals & Clinics, Clinical Research, and Others), By Region - Industry Forecast 2025-2032

Plasma Fractionation Market Competitive Landscape

Plasma Fractionation Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Plasma Fractionation Market?

Who are the key vendors in the Plasma Fractionation Market?

What is the key driver of Plasma Fractionation Market?

What is the key market trend for Plasma Fractionation Market?

Which region accounted for the largest share in Plasma Fractionation Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300